drugset / Trial / NCT03918109
OTO-313 in Subjects With Subjective Tinnitus
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, plasma pharmacokinetics (PK), and exploratory efficacy of OTO-313 administered as an intratympanic injection for the treatment of subjective tinnitus.
Timeline
- Start
- 2019-04-04
- Primary completion
- 2020-05-29
- Completion
- 2020-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GACYCLIDINE | Small molecule | — | Other |